Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Immunic is a biopharmaceutical company that develops a pipeline of selective oral immunology therapies.
ADARx Pharmaceuticals is a genetic medicine company focusing on the base editing of mRNA transcripts.
Alkeus Pharmaceuticals is a Boston-based startup focused on treatments for serious ophthalmic conditions.
Century Therapeutics is a biotechnology company that develops cell therapies for hematological and solid tumor malignancies.
Beacon Therapeutics is a biotechnology company that develops treatments to preserve and restore vision for rare and prevalent eye diseases.
Aviceda Therapeutics is a late-stage pre-clinical biotech company developing drugs for treating glyco-immune diseases.
Synthekine is a development stage biotherapeutics company focused on the engineering of novel specific and potent cytokine therapies.
Tourmaline Bio is a biotechnology company that develops medicines to treat inflammatory and immune diseases in patients.
Athira Pharma is a clinical stage drug development company that specializes in biotechnology and pharmaceutical.
CG Oncology is a clinical-stage biopharmaceutical company focused on the development of oncolytic immunotherapies to combat cancer.
Immunovant is a clinical-stage biopharmaceutical company focused on enabling normal lives for patients with autoimmune diseases.
Alpine Immune Sciences is an immunotherapy company focused on developing treatments for autoimmune and inflammatory diseases.
Cogent Biosciences is a biotechnology company that develops therapies for solid cancer tumors.
Affinia Therapeutics is a biotechnology company developing transformative AAV gene therapies for people with rare and prevalent diseases.
Cidara Therapeutics develops targeted immunotherapies aimed at improving treatment outcomes for patients with serious diseases.
Rapt is focused on the discovery and development of novel small-molecule agents to activate the immune system to eradicate cancer.
Disc Medicine is a biopharmaceutical company that develops therapies for hematologic diseases and rare blood disorders.
ADC Therapeutics develops antibody drug conjugates and non-antibody drug conjugate products.
VectivBio is a biotechnology company committed to making innovative treatments for patients suffering from serious rare diseases.
LB Pharmaceuticals specializes in developing LB-102 (n-Methyl amisulpride) as a treatment for schizophrenia.
Perspective Therapeutics focuses on advancing cancer treatments employing radiation, radiopharmaceuticals, and imaging technology.
CORXEL Pharmaceuticals is a biotechnology company that develops science and medicines for underserved patients.
Mirador Therapeutics develops precision medicines for immune-mediated diseases.
Mirum Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of therapies.
TCG Crossover has invested in 77 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
TCG Crossover's top investment sectors include Biotechnology, Health Care, Therapeutics, Medical, Pharmaceutical. The firm invests across 13 different industry categories.
Among tracked funding rounds, Immunovant received $550.0M in a Post-IPO Equity round. TCG Crossover's total known invested capital is $8.1B.
TCG Crossover's average investment size is $129.1M across its portfolio of 77 companies.
Recent TCG Crossover portfolio additions include Immunic Therapeutics, ADARx Pharmaceuticals, Alkeus Pharmaceuticals, Century Therapeutics, Beacon Therapeutics. These companies were founded in 2020 or later.